{"disease":{"id":"macular-ischemia","name":"macular ischemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05475158","title":"Comparison of OCTA Factors in Patients With or Without Amyloid Pathology: A Prospective Study","phase":"","overall_status":"COMPLETED","enrollment_count":117,"lead_sponsor_name":"Pusan National University Hospital","has_results":false},{"nct_id":"NCT04991350","title":"Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular Edema","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"Cairo University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}